Therapies Offered at Residential Addiction Treatment Programs in the United States
Tamara Beetham, Brendan Saloner, Marema Gaye, Sarah E. Wakeman, Richard G. Frank, Michael L. Barnett
Abstract
This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.
Topics & Concepts
MedicineAddictionFamily medicineMEDLINEGerontologyPsychiatryEnvironmental healthLawPolitical scienceOpioid Use Disorder TreatmentTreatment of Major DepressionSubstance Abuse Treatment and Outcomes